Fundamental Analysis
69 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +96.5% | +32.1% | 2 / 3 | +30.8% | +4.48 pp | +1.55 pp | +4.6% | 1.31 | 26.43 | 10.955 | +30,8% | 271 | +250,8% | 26.43 | 84.06 | −68,6% |
| Pts | 12 | 4 | 8 | 12 | 12 | 8 | 0 | 6 | 12 | |||||||
Valuation annotation:Price: 12.300 (close price on 2026-10-19)EPS (TTM): 465,5
Financial charts
1.Revenue & growth
VND bn10.955Q2/26
1.Revenue & growth
VND bn10.955Q2/26
2.Profit & growth
VND bn12,6Q2/26
3.Profit mix (Penman)
VND bn1.019Q2/26
4.Margins & cost structure
%10.7%Q2/26
5.Returns & cash cycle
% · days1.6%Q2/26
6.Earnings quality & cash
VND bn-1.363Q2/26
7.Asset structure
VND bn55.059Q2/26
8.Funding & debt health
VND bn · times55.059Q2/26
9.Revenue backlog
VND bn1.914Q2/26
10.Valuation
times · %26,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %12Q2/26
Adjusted EPS growth, latest quarter
63.8%
Average adjusted EPS growth, 3 quarters
21.2%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
19.7%
Source: vnstockData through Q2/26